No price history available.
Key financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Total revenue | ¥m | 158,542 | 167,759 | 177,109 | 192,629 | 213,379 | 215,642 | N/A | N/A |
| Operating profit | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net profit | ¥m | 6,560 | 221 | 13,639 | 9,072 | 7,956 | 13,653 | N/A | N/A |
| EPS reported | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating cashflow per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Capex per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Free cash flow | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value equity | ¥m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Book value per share | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Number of shares | m | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| DPS (TTM paid) | ¥ | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Financial summary
Financials in JPY| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | TTM | 2026E | ||
|---|---|---|---|---|---|---|---|---|---|
| Value | |||||||||
| P/E LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/B LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/S LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| P/FCF LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/EBITDA LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EV/Sales LTM | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Earnings Yield LTM | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Quality | |||||||||
| ROE | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| ROIC | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross margin | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Sales | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Growth and momentum | |||||||||
| EPS Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Sales Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Income Growth YoY | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Operating Profit Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend and capital structure | |||||||||
| Dividend Yield | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Dividend Growth | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Payout Ratio | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| FCF/Debt | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net Debt/EBITDA | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| EBIT/Net interest | x | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/market cap | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Net debt/Equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
| Gross debt/equity | % | Locked | Locked | Locked | Locked | Locked | Locked | Locked | Locked |
Ratings
Based on consensus from external analysts. Not Kvantra's opinion.
Company overview
Nikkiso Co., Ltd. is a global enterprise that operates across a diverse range of sectors, including industrial solutions, aerospace components, precision instruments, deep ultraviolet (DUV) LED technology, and medical devices. The company's operations are primarily organized into two main divisions: the Industrial Business segment and the Medical Business segment. The Industrial Business segment focuses on the development, production, sales, and maintenance of specialized industrial pumps, such as leak-proof pumps, accurate metering pumps, and cryogenic pumps vital for liquefied natural gas (LNG) transfer. This division also provides advanced water conditioning systems for thermal and nuclear power plants, along with integrated system products that combine water treatment capabilities with automation and other sophisticated functions. Furthermore, it supplies warm laminating systems, various electronic component manufacturing equipment, carbon fiber reinforced plastic (CFRP) products designed for civilian aircraft, and deep ultraviolet LEDs and their associated technologies. Within the Medical Business segment, Nikkiso is engaged in the manufacturing, distribution, and servicing of products and medical supplies crucial for kidney-related therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Its key offerings encompass comprehensive dialysis systems, dialyzers, blood tubing lines, and powdered dialysate. This segment also produces blood glucose monitoring devices, air purification units, innovative ozone-water hand-washing systems, and microwave-based surgical instruments. Founded in 1950 as Nippon Kikai Keiso Kaisha Ltd., the company officially changed its name to Nikkiso Co., Ltd. in November 1968. Its corporate headquarters are located in Tokyo, Japan.
Similar companies
For informational purposes only. Kvantra provides data and quantitative analysis, not investment advice. KvantraRank is a mechanical model output. Analyst price targets and ratings are sourced from third parties and are not Kvantra recommendations. Past performance does not guarantee future results; all investments carry risk.
No price history available.
Based on consensus from external analysts. Not Kvantra's opinion.
Nikkiso Co., Ltd. is a global enterprise that operates across a diverse range of sectors, including industrial solutions, aerospace components, precision instruments, deep ultraviolet (DUV) LED technology, and medical devices. The company's operations are primarily organized into two main divisions: the Industrial Business segment and the Medical Business segment. The Industrial Business segment focuses on the development, production, sales, and maintenance of specialized industrial pumps, such as leak-proof pumps, accurate metering pumps, and cryogenic pumps vital for liquefied natural gas (LNG) transfer. This division also provides advanced water conditioning systems for thermal and nuclear power plants, along with integrated system products that combine water treatment capabilities with automation and other sophisticated functions. Furthermore, it supplies warm laminating systems, various electronic component manufacturing equipment, carbon fiber reinforced plastic (CFRP) products designed for civilian aircraft, and deep ultraviolet LEDs and their associated technologies. Within the Medical Business segment, Nikkiso is engaged in the manufacturing, distribution, and servicing of products and medical supplies crucial for kidney-related therapies, including hemodialysis, peritoneal dialysis, and continuous renal replacement therapy. Its key offerings encompass comprehensive dialysis systems, dialyzers, blood tubing lines, and powdered dialysate. This segment also produces blood glucose monitoring devices, air purification units, innovative ozone-water hand-washing systems, and microwave-based surgical instruments. Founded in 1950 as Nippon Kikai Keiso Kaisha Ltd., the company officially changed its name to Nikkiso Co., Ltd. in November 1968. Its corporate headquarters are located in Tokyo, Japan.